Cart
0

In Vitro Diagnostics (IVD) Quality Control Product Market by Product Type (Quality Controls (Whole Blood-based Controls, Serum/Plasma-based Controls, Urine-based Controls, Other IVD Quality Controls), Data Management Software, and Quality Assurance Services), by Application (Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Coagulation/Hemostasis, Microbiology, and Others), by End User (Hospitals, Clinical Laboratories, Research & Academic Institutes, and Others), by Manufacturer Type [Instrument Manufacturer Controls and Independent Manufacturer Controls (Third-party Controls and Instrument Manufacturer Controls)] - Global Opportunity Analysis and Industry Forecast, 2014-2022

Get 20% Free Customization In This Report
LI_161792
Pages: 170
Dec 2016 | 3073 Views
 
Author's : Shubhangi Bawkar & Abha Thakur
Tables: 62
Charts: 45
 

IVD Quality Control Product Market Overview:

The Global IVD Quality Control Products Market size is projected to reach $1,052 million by 2022, registering a CAGR of 3.5% during the forecast period from $823 million in 2015. IVD quality controls are samples/materials used to validate the reliability of IVD testing system to ensure accuracy of test results and evaluate the impact of factors such as environmental conditions and operator’s performance on test results. This is attributed to upsurge in demand for third-party quality controls, increase in the number of accredited clinical laboratories, and stringent mandates from accreditation bodies & regulatory agencies regarding the use of controls. Poor reimbursement policies and stringent regulatory norms are expected to hamper the market growth during the analysis period.

Get more information on this report : Request Sample Pages

Segment Review

The global In Vitro Diagnostics quality controls market is segmented on the basis of product type, application, manufacturer type, end user, and region. Based on product type, the market is segmented into quality controls, IVD quality control data management software, and quality assurance services. The quality controls segment dominated the global market by product type in 2015, and is expected to maintain its dominance by 2022, registering the fastest CAGR of 3.7% during the forecast period. This is attributed to the upsurge in demand for quality controls to validate the accuracy, precision, and reliability of IVD test results.

The end users of the market include hospitals, clinical laboratories, research & academic institutes, and others. The hospital segment dominated the IVD quality controls market in 2015, and is expected to maintain its dominance during the forecast period. Based on the manufacturer, the market is bifurcated into instrument manufacturer controls and independent manufacturer controls including third-party controls and instrument specific controls. The independent manufacturer controls segment accounted for the major share of the market in 2015, and is projected to grow at the fastest CAGR during the forecast period, owing to increase in demand for multianalyte and third party controls.

The application areas of the in vitro diagnostics quality controls market include immunochemistry, clinical chemistry, hematology, molecular diagnostics, coagulation, microbiology, and others. The immunochemistry application segment dominated the global IVD quality controls market by application in 2015, and is estimated to maintain this dominance during the analysis period, owing to rise in demand for high-sensitivity immunochemistry tests, and increase in availability of multianalyte controls to validate the accuracy of immunoassay test menus. However, the molecular diagnostics segment is projected to grow at the fastest CAGR of 5.3% during the forecast period, owing to increase in the number of molecular diagnostic tests performed across the globe due to increased acceptance for personalized medicines.

The global IVD quality control market is segmented into four regions, which include North America, Europe, Asia-Pacific, and LAMEA. The North America dominated the global IVD quality controls market in 2015, and is expected to continue its dominance during the forecast period, owing to increase in demand for technologically advanced multianalyte controls and stringent mandates for using controls.

However, Asia-Pacific and LAMEA regions are estimated grow at significant CAGRs of 4.9% and 4.1%, respectively, during the forecast period due to growing number of accredited laboratories in the region and increasing volume of IVD tests performed in the region. In addition, countries such as China, India offer significant growth opportunities for market players due to upsurge in the number of hospitals and clinical pathologies, improvement in healthcare infrastructure, and rise in heath awareness.

The key players profiled in the IVD quality controls market report are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Roche Diagnostics, Abbott Diagnostics, Helena Laboratories, Seracare Life Sciences, Inc., Technopath Clinical Diagnostics, and Sun Diagnostics, LLC.

The other prominent players in the IVD quality controls industry (not profiled in the report) are Zeptometrix Corporation, ISOLAB GmbH, Sysmex Corporation, Fortress Diagnostics, Meril Life Sciences Pvt. Ltd., Multiplicom N.V., Future Diagnostics Solutions B.V., and Surmodics, Inc.

Key Benefits

  • In-depth analysis of the IVD quality controls market is based on market estimations of key segments for the period of 2014‐2022.
  • Comprehensive analysis of factors that drive and restrict the market growth of IVD quality controls industry is provided in the report.
  • Exhaustive analysis of IVD quality controls industry market segments aids in understanding the prospects of IVD quality control products that are presently in use as well as with variants that would gain prominence in the future.
  • Competitive intelligence of leading manufacturers and distributors helps in interpreting the competitive scenario of geographies.
  • The profiles and strategies of key market players are thoroughly analyzed in the report to understand the competitive outlook of the market.

In Vitro Diagnostics (IVD) Quality Control Product Market Key Segments:

By Product Type

  • Quality Controls
  • Whole Blood-based Controls
  • Serum/Plasma-based Controls
  • Urine-based Controls
  • Other IVD Quality Controls
  • Data Management Solutions
  • Quality Assurance Services

By Application

  • Clinical Chemistry
  • Immunochemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation/Hemostasis
  • Microbiology
  • Others

By End User

  • Hospitals
  • Clinical Laboratories
  • Research and Academic Institutes
  • Others

By Manufacturer Type

  • Instrument Manufacturer Controls
  • Independent Manufacturer Controls
  • Third-party Controls
  • Instrument Manufacturer Controls

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY:
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies

3.3. PORTER’S FIVE FORCES ANALYSIS

3.3.1. Bargaining Power Of Suppliers
3.3.2. Bargaining Power Of Buyers
3.3.3. Threat Of New Entrants
3.3.4. Intensity Of Competitive Rivalry
3.3.5. Threat Of Substitutes

3.4. MARKET SHARE ANALYSIS, 2015
3.5. MARKET SHARE ANALYSIS FOR IVD QUALITY CONTROLS
3.6. MARKET SHARE ANALYSIS FOR DATA MANAGEMENT SOLUTIONS
3.7. MARKET SHARE ANALYSIS FOR QUALITY ASSURANCE SERVICES
3.8. MARKET DYNAMICS

3.8.1. Drivers

3.8.1.1. Growing number of accredited clinical laboratories
3.8.1.2. Increasing mandates on the use of quality controls from regulatory and accreditation bodies
3.8.1.3. Increasing Adoption of Third-Party multi-analyte Quality Controls

3.8.2. Restraints

3.8.2.1. Stringent regulatory requirements for the approval and commercialization of IVD and their quality control Products
3.8.2.2. Inadequate reimbursement policies for IVD quality control

3.8.3. Opportunities

3.8.3.1. developing economies offer lucrative growth opportunities

Chapter: 4 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE

4.1. OVERVIEW
4.2. QUALITY CONTROLS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Whole Blood-Based Controls

4.2.4.1. Market size and forecast

4.2.5. Serum/plasma-based Controls

4.2.5.1. Market size and forecast

4.2.6. Urine-based controls

4.2.6.1. Market size and forecast

4.2.7. Other source-based controls

4.2.7.1. Market size and forecast

4.3. DATA MANAGEMENT SOFTWARE

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. QUALITY ASSURANCE SERVICES

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION

5.1. OVERVIEW
5.2. CLINICAL CHEMISTRY

5.2.1. Market size and forecast

5.3. IMMUNOCHEMISTRY

5.3.1. Market size and forecast

5.4. HEMATOLOGY

5.4.1. Market size and forecast

5.5. MOLECULAR DIAGNOSTICS

5.5.1. Market size and forecast

5.6. COAGULATION/HEMOSTASIS

5.6.1. Market size and forecast

5.7. MICROBIOLOGY

5.7.1. Market size and forecast

5.8. OTHERS

5.8.1. Market size and forecast

Chapter: 6 IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. INSTRUMENT MANUFACTURER CONTROLS

6.2.1. Market size & forecast

6.3. INDEPENDENT MANUFACTURER CONTROLS

6.3.1. Market size & forecast
6.3.2. Third-party controls

6.3.2.1. Market Size & Forecast

6.3.3. Instrument-Specific Controls

6.3.3.1. Market Size & Forecast

Chapter: 7 IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER

7.1. OVERVIEW
7.2. CLINICAL LABORATORIES

7.2.1. Market size and forecast

7.3. HOSPITALS

7.3.1. Market size and forecast

7.4. RESEARCH AND ACADEMIC INSTITUTES

7.4.1. Market size and forecast

7.5. OTHERS

7.5.1. Market size and forecast

Chapter: 8 IVD QUALITY CONTROL PRODUCTS MARKET, BY GEOGRAPHY

8.1. INTRODUCTION

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.4. U.S. market size and forecast
8.2.5. Canada market size and forecast
8.2.6. Mexico market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. Germany market size and forecast
8.3.5. France market size and forecast
8.3.6. UK: market size and forecast
8.3.7. Italy market size and forecast
8.3.8. Spain market size and forecast
8.3.9. Rest of Europe: market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. Japan market size and forecast
8.4.5. China market size and forecast
8.4.6. India market size and forecast
8.4.7. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. Latin America market size and forecast
8.5.5. Middle East market size and forecast
8.5.6. Africa market size and forecast

Chapter: 9 COMPANY PROFILES

9.1. SERACARE LIFE SCIENCES, INC.

9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves and developments

9.2. TECHNOPATH CLINICAL DIAGNOSTICS

9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves and developments

9.3. BIO-RAD LABORATORIES INC.

9.3.1. Company overview
9.3.2. Business operating segments
9.3.3. Business performance
9.3.4. Key strategic moves and developments

9.4. ABBOTT LABORATORIES

9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance

9.5. DANAHER CORPORATION

9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves and developments

9.6. HELENA LABORATORIES CORPORATION

9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance

9.7. ORTHO-CLINICAL DIAGNOSTICS, INC.

9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves and developments

9.8. RANDOX LABORATORIES LTD.

9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves and developments

9.9. F. HOFFMANN-LA ROCHE LTD.

9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves and developments

9.10. SUN DIAGNOSTICS, LLC

9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Sun Diagnostics, LLC.: business segments
9.10.4. Business performance

 LIST OF TABLES

TABLE 1. GLOBAL IVD QUALITY CONTROLS PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 2. GLOBAL IVD QUALITY CONTROLS MARKET, BY SOURCE TYPE, 2014-2022 ($MILLION)
TABLE 3. IVD QUALITY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4. WHOLE BLOOD-BASED QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 5. SERUM-BASED QUALITY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6. URINE-BASED QUALITY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7. OTHER SOURCE-BASED QUALITY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8. IVD QUALITY CONTROLS DATA MANAGEMENT SOFTWARE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9. IVD QUALITY ASSURANCE SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10. GLOBAL IVD QUALITY CONTROLS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 11. CLINICAL CHEMISTRY QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12. IMMUNOCHEMISTRY QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13. HEMATOLOGY QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14. MOLECULAR DAIGNOSTICS QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15. COAGULATION/HEMOTASIS QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16. MICROBIOLOGY QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 17. OTHER QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18. GLOBAL IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT MANUFACTURER TYPE, 2015-2022 ($MILLION)
TABLE 19. INSTRUMENT MANUFACTURER CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20. GLOBAL INDEPENDENT MANUFACTURER CONTROLS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 21. INDEPENDENT MANUFACTURER CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 22. THIRD-PARTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23. INSTRUMENT SPECIFIC CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 24. GLOBAL IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2015-2022 ($MILLION)
TABLE 25. IVD QUALITY CONTROL PRODUCTS MARKET FOR CLINICAL LABORATORIES, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 26. IVD QUALITY CONTROL PRODUCTS MARKET FOR HOSPITALS, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 27. IVD QUALITY CONTROL PRODUCTS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 28. IVD QUALITY CONTROL PRODUCTS MARKET FOR OTHER END USERS, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 29. IVD QUALITY CONTROL PRODUCTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 30. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 31. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 32. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 33. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 34. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE, 2014-2022 ($MILLION)
TABLE 35. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 36. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 37. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 38. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 39. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE, 2014-2022 ($MILLION)
TABLE 40. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 41. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 42. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 43. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 44. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE, 2014-2022 ($MILLION)
TABLE 45. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 46. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 47. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 48. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 49. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE, 2014-2022 ($MILLION)
TABLE 50. SERACARE LIFE SCIENCES, INC.: COMPANY SNAPSHOT
TABLE 51. SERACARE LIFE SCIENCES, INC.: BUSINESS SEGMENTS
TABLE 52. TECHNOPATH CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 53. TECHNOPATH CLINICAL DIAGNOSTICS: BUSINESS SEGMENTS
TABLE 54. BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
TABLE 55. BIO-RAD LABORATORIES INC.: BUSINESS SEGMENTS
TABLE 56. ABBOTT: COMPANY SNAPSHOT
TABLE 57. ABBOTT: BUSINESS SEGMENTS
TABLE 58. DANAHER: COMPANY SNAPSHOT
TABLE 59. DANAHER: BUSINESS SEGMENTS
TABLE 60. HELENA LABORATORIES CORPORATION: COMPANY SNAPSHOT
TABLE 61. HELENA LABORATORIES CORPORATION: BUSINESS SEGMENTS
TABLE 62. ORTHO-CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 63. ORTHO-CLINICAL DIAGNOSTICS, INC.: OPERATING SEGMENTS
TABLE 64. RANDOX LABORATORIES: COMPANY SNAPSHOT
TABLE 65. RANDOX LABORATORIES: OPERATING SEGMENTS
TABLE 66. ROCHE: OPERATING SEGMENTS
TABLE 67. SUN DIAGNOSTICS, LLC: COMPANY SNAPSHOT

 LIST OF FIGURES

FIGURE 1. GLOBAL IVD QUALITY CONTROL PRODUCT MARKET, 2014-2022
FIGURE 2. GLOBAL IVD QUALITY CONTROL PRODUCT MARKET, BY GEOGRAPHY, 2014-2022
FIGURE 3. MARKET SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND TYPE 2014-2016
FIGURE 7. PORTER’S FIVE FORCES ANALYSIS
FIGURE 8. MARKET SHARE ANALYSIS, 2015
FIGURE 9. MARKET SHARE ANALYSIS FOR IVD QUALITY CONTROLS, 2015
FIGURE 10. MARKET SHARE ANALYSIS FOR DATA MANAGEMENT SOLUTIONS, 2015
FIGURE 11. MARKET SHARE ANALYSIS FOR QUALITY ASSURANCE SERVICES, 2015
FIGURE 12. IVD QUALITY CONTROL MARKET DRIVERS & RESTRAINTS
FIGURE 13. MEDICAL DEVICE DEVELOPMENT AND APPROVAL PROCEDURE
FIGURE 14. GLOBAL IVD QUALITY CONTROLS PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
FIGURE 15. GLOBAL IVD QUALITY CONTROLS PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
FIGURE 16. NORTH AMERICA IVD QUALITY CONTROL MARKET, 2014-2022 ($MILLION)
FIGURE 17. U.S. IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 18. CANADA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 19. MEXICO IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 20. EUROPE IVD QUALITY CONTROL MARKET, 2014-2022 ($MILLION)
FIGURE 21. GERMANY IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 22. FRANCE IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 23. UK IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 24. ITALY IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 25. SPAIN IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 26. REST OF EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 27. ASIA-PACIFIC IVD QUALITY CONTROL MARKET, 2014-2022 ($MILLION)
FIGURE 28. JAPAN IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 29. CHINA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 30. INDIA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 31. REST OF ASIA-PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 32. LAMEA IVD QUALITY CONTROL MARKET, 2014-2022 ($MILLION)
FIGURE 33. LATIN AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 34. MIDDLE EAST IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 35. AFRICA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)
FIGURE 36. BIO-RAD LABORATORIES INC.: BUSINESS PERFORMANCE
FIGURE 37. ABBOTT REVENUE, 2013-2015 ($MILLION)
FIGURE 38. ABBOTT REVENUE SHARE, BY OPERATING SEGMENT, 2015 (%)
FIGURE 39. ABBOTT REVENUE SHARE, BY GEOGRAPHY, 2015 (%)
FIGURE 40. DANAHER REVENUE, 2013-2015 ($MILLION)
FIGURE 41. DANAHER REVENUE SHARE, BY OPERATING SEGMENT, 2015 (%)
FIGURE 42. DANAHER REVENUE SHARE, BY GEOGRAPHY, 2015(%)
FIGURE 43. ROCHE: REVENUE, 2013-2015 ($MILLION)
FIGURE 44. ROCHE REVENUE SHARE, BY PRODUCT, 2015 (%)
FIGURE 45. ROCHE REVENUE SHARE, BY GEOGRAPHY, 2015 (%)

 

In vitro diagnostics (IVD) quality controls (QC) are liquid or lyophilized samples or materials, which contain an established amount of analyte being tested. These controls are used in laboratories to ensure reliability and accuracy of test results in an in vitro setting. Quality control is used for monitoring the analytical performance of clinical laboratory testing processes. The IVD quality control products market is forecast to grow at a CAGR of 3.5% from 2016 to 2022. The market is driven by factors such as increase in the number of accredited laboratories across the globe, stringent mandates regarding the use of quality control products, and upsurge in the number of IVD test volumes across the globe.

The IVD quality control materials are manufactured by both IVD product manufacturers and independent third party manufacturers. The IVD quality control products market is divided on the basis of manufacturer into instrument manufacturer controls and independent manufacturer controls. The independent manufacturer controls segment is forecast to grow at a significant CAGR during the analysis period, owing to increase in adoption of multianalyte third party controls. These multianalyte controls decrease the operating cost of laboratories involved in maintaining a wide range of quality controls for IVD instrument (analyzer) to validate their precision, accuracy, and reliability. Moreover, long shelf life of third party controls enables the use of a single lot of controls rather than using multiple lots of reagents and calibrators.

North America and Europe dominated the IVD quality control products market in 2015. However, emerging economies such as China, India, and Brazil are expected offer significant growth opportunities to key players in the IVD quality control products market during the high acceptance of third party quality controls, increase in the number of accredited laboratories, upsurge in volumes of IVD tests performed in the region, improvement in healthcare infrastructure, and rise in health awareness. Bio-Rad Laboratories, Thermo Fisher Scientific, and Randox Laboratories are the key players with significant shares in the global IVD quality control products market.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
In Vitro Diagnostics (IVD) Quality Control Product Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $5473 $4926
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $6081 $5473
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $6981 $5934
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $8385 $6708
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $11693 $8770
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo